Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of T5O.DE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for CytoTools AG stock after losing 0%
(Updated on May 10, 2024)

Sell candidate since May 09, 2024 PDF

No changes to the price of CytoTools AG stock on the last trading day (Friday, 10th May 2024). During the last trading day the stock fluctuated 0% from a day low at 0.406€ to a day high of 0.406€. The price has fallen in 4 of the last 10 days and is down by -13.25% for this period.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.53% during the next 3 months and, with a 90% probability hold a price between 0.427€ and 0.714€ at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

T5O.DE Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, May 07, 2024, and so far it has risen 17.34%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The CytoTools AG stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at 0.424€ and 0.412€. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for CytoTools AG stock

CytoTools AG finds support from accumulated volume at 0.396€ and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved 0€ between high and low, or 0%. For the last week the stock has had daily average volatility of 9.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (T5O.DE) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect CytoTools AG to open at 0.406€, and during the day (based on 14 day Average True Range), to move between 0.371€ and 0.441€, which gives a possible trading interval of +/-0.0346€ (+/-8.53%) up or down from last closing price. If CytoTools AG takes out the full calculated possible swing range there will be an estimated 17.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at 0.408€ (0.49%) than the support at 0.396€ (2.46%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is CytoTools AG stock A Buy?

The CytoTools AG stock holds several negative signals and despite the positive trend, we believe CytoTools AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.087 Sell Candidate Unchanged

Predicted Opening Price for CytoTools AG of Monday, May 13, 2024

Fair opening price May 13, 2024 Current price
0.406€ ( 0.00000000%) 0.406€

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for T5O.DE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.406 0.00000000 %
R2 0.406 0.00000000 %
R1 0.406 0.00000000 %
Current price: 0.406
Support S1 0.406 0.00000000 %
S2 0.406 0.00000000 %
S3 0.406 0.00000000 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.458 12.81 %
R2 0.418 2.96 %
R1 0.408 0.493 %
Current price 0.406
Support S1 0.396 -2.46%
S2 0.374 -7.88%
S3 0.346 -14.78%

FAQ

What is the symbol for CytoTools AG Stock and on which exchange is it traded?
The symbol for CytoTools AG is T5O.DE and it is traded on the GER (Deutsche Börse XETRA).

Should I buy or sell CytoTools AG Stock?
The CytoTools AG stock holds several negative signals and despite the positive trend, we believe CytoTools AG will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy CytoTools AG Stock?
CytoTools AG Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CytoTools AG Stock.

What's the current price of CytoTools AG Stock?
As of the end of day on the May 10, 2024, the price of an CytoTools AG (T5O.DE) share was 0.406€.

What is the 52-week high and low for CytoTools AG Stock?
The 52-week high for CytoTools AG Stock is 2.34€ and the 52-week low is 0.300€.

What is the market capitalization of CytoTools AG Stock?
As of the May 10, 2024, the market capitalization of CytoTools AG is 2.016M.

When is the next earnings date for CytoTools AG?
The upcoming earnings date for CytoTools AG is Aug 02, 2024.
Click to get the best stock tips daily for free!

About CytoTools AG

CytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies. The company's therapies include proprietary small molecules and biologics to provide treatment options in dermatology, cardiology and angiology, urology, and oncology. Its lead clinical product is DermaPro that has completed Phase III clinical trials for the treatment of diabetic foot ulcers in India; is in Phase III clinical trials for diabetic foot ulcer ... T5O.DE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT